-
CaSMO Recommendations for Prevention and Treatment of Cutaneous Adverse Events Related to Cancer Therapies in Darker Skin Phototypes
19 Dec 2025 08:28 GMT
… in research, medical textbooks, and medical education. In … by cancer treatment including radiation dermatitis, drug-induced lichen … inhibitors, mammalian target of Rapamycin (mTOR) inhibitors, and … personal fees from LEO Pharmaceutical, personal fees from …
-
<![CDATA[Dermatologic Effects of Energy and High Protein Drinks]]>
19 Dec 2025 16:41 GMT
… the mammalian target of rapamycin complex 1 (mTORC1) … to more effective, holistic treatment. Overall, this process empowers … year medical student at Meharry Medical College, School of Medicine in … nonmedical prescription drug use, and illicit drug use are …
-
Dexmedetomidine Suppresses Mitochondrial Autophagy and Apoptosis While Promoting Proliferation in Breast Cancer Cells in vitro via PI3K/AKT Signaling
20 Dec 2025 08:31 GMT
… /mammalian target of rapamycin (mTOR) have been found … obtained from the Wuhan Pricella Biotechnology Co., Ltd. Cells … Figure 4 Effects of different drug treatments on proliferation, cell viability, … the 2023 Zhejiang Province Medical and Health Science and …
-
For Black Women with Breast Cancer, Ultra-Processed Foods May Worsen Health Outcomes
18 Dec 2025 20:47 GMT
… chief of the Department of Medicine at Rutgers Robert Wood … Johnson Medical School. During home interviews … at Rutgers Robert Wood Johnson Medical School. "I’d … of the mammalian target of rapamycin signaling pathway, a cellular …
-
Biodexa Announces Pricing of $10 Million Public Offering
18 Dec 2025 13:30 GMT
… for the treatment of diseases with unmet medical needs, … jurisdiction. About Biodexa Pharmaceuticals PLC Biodexa Pharmaceuticals PLC (listed … of rapamycin, also known as sirolimus. Rapamycin is … by three proprietary drug delivery technologies focused …
-
StockWatch: Wall Street’s Leaders and Laggards of 2025
21 Dec 2025 22:05 GMT
… on biopharma. The iShares Biotechnology ETF (NASDAQ: IBB … any time point following treatment.
#2. Cidara Therapeutics
… TOIVA trial (NCT06653842) evaluating QTORIN™ 3.9% rapamycin anhydrous … malformations.
#4. Terns Pharmaceuticals
NASDAQ: TERN
2025 Increase: + …
-
Membrane-Camouflaged Biomimetic Nanoparticles for Effective Ischemic Stroke Therapeutics? A Comprehensive Review of the Literature
20 Dec 2025 13:25 GMT
… treatment safety.4 Fingolimod hydrochloride (FTY720), an Food and Drug Administration (FDA … ; RAPA@BMHOP, Rapamycin loaded in Bioengineered … ], Zhejiang Medical Association Clinical Medical Research Special … of nanotechnology products. Pharmaceutics. 2021;13( …
-
Old age isn’t the reason people die: New research reveals what really claims the lives of even healthy centenarians
20 Dec 2025 14:08 GMT
… autopsies, as relatives and doctors often misinterpret the cause … on anti-ageing interventions, like drugs, fasting, or genetic changes … animals. This means these treatments often change overall body … cooking smoke For example, rapamycin can extend the life …
-
Do humans die due to ageing? The hidden reason is not 'old age' but something far more common
20 Dec 2025 11:52 GMT
… traced back to a defined medical cause, not to a … autopsies matter. Without them, doctors and families often misjudge the … ageing itself. For example, rapamycin extends the lifespan of mice … . This suggests that such treatments delay specific diseases instead of …
-
Substantial Increase in the Costs of Antineoplastic Agents in the USA from 2010 to 2021
18 Dec 2025 00:29 GMT
… mammalian target of rapamycin inhibitors (403), … , including significant pharmaceutical innovations in antineoplastic … vaccines, and cytokine therapy.29 However, these treatments … and frequencies: prescription medications—drug information (RXQ_DRUG). 2021.
16 …